
|Videos|August 1, 2017
Second-Line Therapy Options in Metastatic Renal Cell Carcinoma
Author(s)Neeraj Agarwal, MD
This video reviews the various treatment options for metastatic renal cell carcinoma in the second-line setting, including considerations for different toxicity profiles.
Advertisement
In this video, Neeraj Agarwal, MD, of the University of Utah Huntsman Cancer Institute, reviews the various treatment options for metastatic renal cell carcinoma in the second-line setting, including considerations of the different toxicity profiles.
Agarwal spoke on this topic at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CGTlive®
1
Sangamo Starts Putting BLA for Fabry Disease Gene Therapy Isa-Vec in Front of FDA
2
CGTLive®’s Weekly Rewind – December 19, 2025
3
The Implications of the Final Data From Hemgenix’s HOPE-B Trial
4
What the Field of Cell and Gene Therapy Needs Most in the Current Moment
5


































